Equipment financing and leasing for Med spa and aesthetics
Equipment financing for med spa and aesthetics
Direct answer
Med spa device purchases are financed as equipment loans or leases running 24 to 84 months, with the structure chosen deciding the tax treatment. Lenders read revenue per device and the ownership structure closely. Practition Finance explains the difference between structures and, by state, refers the request to funding partners.
As of October 2026
Aesthetic devices carry a wide range of ticket sizes, and a med spa adding a laser, a body contouring system, or an injectable delivery platform typically finances the purchase rather than paying cash, since the equipment generates revenue immediately and the financing structure directly affects the tax treatment of that purchase. An equipment finance agreement, a fair market value lease, and a 10% PUT lease each produce a different depreciation and buyout outcome.
A med spa's ownership structure matters more to an equipment lender than it does in most other healthcare categories, because corporate practice of medicine rules can separate the management services organization from the professional corporation, and a lender needs to know which entity is actually signing the note and which entity owns the equipment once the note is paid off. This gets sorted out before financing terms are quoted, not after.
Revenue per device is the operating number a lender weighs most heavily when financing a med spa's next machine, since it demonstrates whether the practice's existing equipment fleet is producing enough return to support debt service on an additional unit. A med spa financing its third or fourth device with a strong utilization history on the first two moves through underwriting faster than a first-time buyer with no device revenue track record.
Why this program fits your situation
Equipment financing fits med spas because device economics, tax treatment, and the ownership structure all shape the request in ways specific to this category
Device ticket size sets the financing structure
Aesthetic devices span a wide ticket range, and the financing structure a med spa chooses, whether an equipment finance agreement, a $1 buyout, a fair market value lease, or a 10% PUT, changes both the monthly payment and the tax outcome at the end of the term. A med spa owner financing a higher-ticket device should model the buyout cost under each structure before signing, since the cheaper monthly payment on a fair market value lease can cost more in total once the end-of-term buyout is included.
Section 179 and bonus depreciation apply directly to device purchases
A med spa financing equipment through a structure that qualifies as a purchase, rather than a true lease, can typically apply the current Section 179 deduction limit and the current bonus depreciation rate against the device cost in the year it is placed in service. An owner who structures the deal purely around the lowest monthly payment, without consulting a tax advisor about which structure preserves this treatment, can leave a meaningful deduction unclaimed in the year the device generates revenue.
Revenue per device is the underwriting anchor
A lender financing a med spa's next device wants to see how the existing fleet is performing, since revenue per device on units already in service is the clearest signal of whether an additional device will support its own payment. A med spa that tracks utilization and revenue by device, rather than only aggregate treatment revenue, can present that data directly to a lender and move through underwriting with fewer requests for supplemental documentation.
The MSO and PC structure decides who signs
In states with strict corporate practice of medicine enforcement, the management services organization and the professional corporation are separate legal entities, and an equipment lender needs to know upfront which entity holds title to the device and which entity is obligated on the note. A med spa that has not resolved this structure before approaching a lender adds delay to the financing timeline, since the lender's documentation has to match the actual ownership chain exactly.
Directional terms for a file like yours
How the equipment numbers apply to a med spa device purchase
| What it measures | Market range | Confidence | How to read it |
|---|---|---|---|
| Device ticket range | $10,000 to $250,000 and above5 | DirectionalAugust 2026 | Aesthetic device pricing spans a wide range, and the financing request should reflect the actual vendor quote, not a category average. |
| Section 179 limit | $2,560,000, phase-out from $4,090,0006 | VerifiedAugust 2026 | A device purchase structured to qualify can be deducted up to the current annual limit in the year it is placed in service, before the phase-out begins. |
| Bonus depreciation | 100%, permanent, property acquired after January 19, 2025 (OBBBA)7 | VerifiedAugust 2026 | Qualifying equipment purchased under current law can be fully depreciated in year one, changing the after-tax cost of a device financed as a purchase. |
| Average revenue per location | $1,398,8338 | VerifiedAugust 2026 | Average annual revenue per med spa location is the benchmark a lender compares against when weighing whether a new device fits the practice's scale. |
| CPOM posture | California, Texas, and New York strict, Arizona, Colorado, and Washington permissive with a medical director9 | VerifiedAugust 2026 | States with strict corporate practice of medicine enforcement require the MSO and PC structure to be resolved before an equipment lender will finalize the note. |
These are ranges the market publishes, current as of the date beside each one. None of it is a quote, an offer, or an indication of terms.
The 3 things that cost owners here
The cheapest monthly payment wins without checking the buyout
A med spa owner comparing financing quotes on monthly payment alone often selects a fair market value lease with a low payment, then faces a buyout cost at the end of the term that makes the total cost of ownership higher than an equipment finance agreement would have been. The buyout terms should be compared side by side with the monthly payment before signing, especially on higher-ticket devices where the buyout difference compounds across several units.
The MSO and PC structure gets sorted out after financing is quoted
An owner who applies for equipment financing before confirming which entity, the MSO or the PC, will hold the note and title to the device often has to restart the documentation process once the lender's compliance review flags the mismatch. In states with strict corporate practice of medicine rules, this delay can push a device delivery date back by weeks. Resolving the entity structure with legal counsel before requesting financing terms avoids the restart.
Device utilization data is never tracked separately
A med spa that reports only aggregate treatment revenue, without breaking out revenue per device, cannot show a lender the utilization data that supports financing an additional unit, which forces the underwriting to rely on the practice's overall financials alone. This produces a more conservative offer or more documentation requests than a med spa that can point to a specific device's revenue history. Tracking utilization by device from day one strengthens every future financing request.
Run your numbers
Equipment lease versus loan calculator
Compare an equipment finance agreement against a fair market value lease on a specific device quote
Open the calculatorWhat owners ask about this combination
01What is the difference between an equipment loan and a lease for a med spa device?
An equipment finance agreement or a loan with a $1 buyout treats the device as owned from day one for tax purposes, while a fair market value lease keeps ownership with the lender until a buyout payment at term end. Which structure fits a specific device purchase depends on the med spa's tax position, a question for the funding partner and the practice's accountant.
02Can Section 179 be used on a financed med spa device?
Yes, a device financed through a structure that qualifies as a purchase can typically be deducted under the current Section 179 limit in the year it is placed in service, subject to the phase-out threshold. Practition Finance reviews which financing structures preserve this treatment before a med spa owner signs a device quote.
03Does the MSO and PC structure affect equipment financing approval?
It affects who signs the note and who holds title to the device, particularly in states with strict corporate practice of medicine enforcement, and a lender needs this resolved before finalizing documentation. Identifying the correct signing entity early keeps the equipment financing timeline from stalling.
04How fast can a med spa finance a new device?
Purchases under the application-only threshold often move through underwriting in a matter of days based on financials alone, while larger purchases above that threshold require a fuller documentation package and take longer. Practition Finance sets realistic timelines with med spa owners based on the specific device ticket size involved.
05What does a lender look at before financing a second or third device?
A lender weighs revenue per device on the existing fleet to judge whether an additional unit will support its own payment, alongside membership revenue and the overall treatment menu. Tracking utilization by device keeps this data ready when the next equipment request is submitted.
Sources
- 1Section179.org
- 2IRS depreciation guidance
- 3American Med Spa Association
- 4US Bank equipment financing
- 5Lender program pages
- 6Section179.org, Ameris Bank, Rev. Proc. 2025-32
- 7Section179.org, US Bank, AE Tax Advisors
- 8AmSpa via industry statistics page
- 9Pabau, Cohen Healthcare Law, ByrdAdatto, medspastandards
Model a specific device quote against both a loan structure and a lease structure before ordering